Prevention strategies of esophageal stenosis after endoscopic resection for superficial esophageal cancer: a Bayesian network meta-analysis.
Abstract
[INTRODUCTION] What interventions effectively prevent postoperative stenosis following endoscopic resection (ER) of superficial esophageal cancer? This study aimed to identify effective interventions or combinations through a systematic review and network meta-analysis.
[METHODS] Six databases were systematically searched for eligible studies up to 30 April 2023, on interventions to prevent esophageal stenosis post-ER. Odds ratios (ORs) evaluated stenosis rate (primary outcome) and complications (secondary outcome), while mean differences (MD) evaluated endoscopic balloon dilatation (EBD) sessions post-stenosis.
[RESULTS] Twenty-three studies involving 1271 patients and 11 different interventions were included. Eight interventions were effective in preventing post-ER stenosis: oral hydrocortisone sodium succinate and aluminum phosphate gel (OHA) (OR: 0.02, 95% credible interval [CrI]: 0.00-0.11), polyglycolic acid (PGA) + ST (OR: 0.02, 95% CrI: 0.00-0.23), oral tranilast (OT) + preemptive endoscopic balloon dilatation (PEBD) (OR: 0.08, 95% CrI: 0.01-0.77), botulinum toxin (BT) (OR: 0.10, 95% CrI: 0.03-0.32), ST (OR: 0.08, 95% CrI: 0.01-0.67), oral steroid (OS) (OR: 0.11, 95% CrI: 0.05-0.28), endoscopic triamcinolone injection (ETI) + OS (OR: 0.17, 95% CrI: 0.07-0.42), and ETI (OR: 0.18, 95% CrI: 0.11-0.30). Five interventions significantly reduced EBD sessions: PGA + ST (MD: -5.78, 95% CrI: -11.04 to -1.21), ETI + OS (MD: -3.27, 95% CrI: -5.37 to -0.72), OS (MD: -6.18, 95% CrI: -9.43 to -3.38), ETI (MD: -3.81, 95% CrI: -5.74 to -1.99), and BT (MD: -2.16, 95% CrI: -4.12 to -0.40). None of the interventions significantly increased complications.
[CONCLUSIONS] This study confirmed the efficacy of OS, ETI, and ETI + OS and verified five other interventions (OHA, PGA + ST, OT + PEBD, BT, and ST) in preventing stenosis. Notably, PGA + ST and BT also reduced the number of EBD sessions.
[METHODS] Six databases were systematically searched for eligible studies up to 30 April 2023, on interventions to prevent esophageal stenosis post-ER. Odds ratios (ORs) evaluated stenosis rate (primary outcome) and complications (secondary outcome), while mean differences (MD) evaluated endoscopic balloon dilatation (EBD) sessions post-stenosis.
[RESULTS] Twenty-three studies involving 1271 patients and 11 different interventions were included. Eight interventions were effective in preventing post-ER stenosis: oral hydrocortisone sodium succinate and aluminum phosphate gel (OHA) (OR: 0.02, 95% credible interval [CrI]: 0.00-0.11), polyglycolic acid (PGA) + ST (OR: 0.02, 95% CrI: 0.00-0.23), oral tranilast (OT) + preemptive endoscopic balloon dilatation (PEBD) (OR: 0.08, 95% CrI: 0.01-0.77), botulinum toxin (BT) (OR: 0.10, 95% CrI: 0.03-0.32), ST (OR: 0.08, 95% CrI: 0.01-0.67), oral steroid (OS) (OR: 0.11, 95% CrI: 0.05-0.28), endoscopic triamcinolone injection (ETI) + OS (OR: 0.17, 95% CrI: 0.07-0.42), and ETI (OR: 0.18, 95% CrI: 0.11-0.30). Five interventions significantly reduced EBD sessions: PGA + ST (MD: -5.78, 95% CrI: -11.04 to -1.21), ETI + OS (MD: -3.27, 95% CrI: -5.37 to -0.72), OS (MD: -6.18, 95% CrI: -9.43 to -3.38), ETI (MD: -3.81, 95% CrI: -5.74 to -1.99), and BT (MD: -2.16, 95% CrI: -4.12 to -0.40). None of the interventions significantly increased complications.
[CONCLUSIONS] This study confirmed the efficacy of OS, ETI, and ETI + OS and verified five other interventions (OHA, PGA + ST, OT + PEBD, BT, and ST) in preventing stenosis. Notably, PGA + ST and BT also reduced the number of EBD sessions.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 기법 | endoscopic
|
내시경 | dict | 5 | |
| 시술 | botulinum toxin
|
보툴리눔독소 주사 | dict | 1 | |
| 해부 | post-ER
|
scispacy | 1 | ||
| 해부 | oral hydrocortisone sodium succinate
|
scispacy | 1 | ||
| 합병증 | esophageal
|
scispacy | 1 | ||
| 합병증 | esophageal stenosis
|
scispacy | 1 | ||
| 합병증 | oral
|
scispacy | 1 | ||
| 합병증 | oral steroid
|
scispacy | 1 | ||
| 약물 | hydrocortisone sodium succinate
|
C0770560
hydrocortisone sodium succinate
|
scispacy | 1 | |
| 약물 | aluminum phosphate
|
C0051519
aluminum phosphate
|
scispacy | 1 | |
| 약물 | OHA
|
scispacy | 1 | ||
| 약물 | polyglycolic acid
|
C0032502
polyglycolic acid
|
scispacy | 1 | |
| 약물 | PGA
→ polyglycolic acid
|
C0032502
polyglycolic acid
|
scispacy | 1 | |
| 약물 | tranilast
|
C0146337
tranilast
|
scispacy | 1 | |
| 약물 | steroid
|
C0038317
Steroids
|
scispacy | 1 | |
| 약물 | triamcinolone
|
C0040864
triamcinolone
|
scispacy | 1 | |
| 약물 | [INTRODUCTION] What
|
scispacy | 1 | ||
| 약물 | EBD
→ endoscopic balloon dilatation
|
scispacy | 1 | ||
| 약물 | [CONCLUSIONS]
|
scispacy | 1 | ||
| 질환 | esophageal stenosis
|
C0014866
Esophageal Stenosis
|
scispacy | 1 | |
| 질환 | esophageal cancer
|
C0014859
Esophageal Neoplasms
|
scispacy | 1 | |
| 질환 | postoperative stenosis
|
scispacy | 1 | ||
| 질환 | stenosis
|
C0678234
Stenosis Morphology
|
scispacy | 1 | |
| 질환 | superficial esophageal cancer
|
scispacy | 1 | ||
| 질환 | ORs
→ Odds ratios
|
scispacy | 1 | ||
| 기타 | Bayesian network
|
scispacy | 1 | ||
| 기타 | network
|
scispacy | 1 | ||
| 기타 | patients
|
scispacy | 1 |
MeSH Terms
Humans; Esophageal Stenosis; Esophageal Neoplasms; Postoperative Complications; Bayes Theorem; Esophagoscopy; Dilatation
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Local therapeutic strategies for neurocutaneous dysesthesia: from capsaicin to cannabinoids.
- Comparative efficacy of intralesional therapies for keloid scars: a network meta-analysis.
- Adverse neurological events following botulinum toxin type A: A case series of post-injection seizures and paralysis.
- Decreased utilization of component separation techniques over time in complex abdominal wall reconstruction following introduction of preoperative botulinum toxin A.
- Current Perspectives on Pectoralis Minor Syndrome: A Narrative Review.